Abstract
INTRODUCTION
Functional constipation (FC), also called chronic idiopathic constipation (CIC), is a common functional gastrointestinal disorder, affecting 12%-19% of overall global populations, [1] [2] [3] and with a mean annual health care cost per patient of USD 7522. 4 In addition, a recent study of 2870 subjects reported that constipation had a negative impact on their health-related quality of life (QOL). 5 Causes of constipation are multi-factorial and can include dietary factors (e. g., low fiber), motility disturbances (outlet delay, slow transit time), lack of exercise, stress and eating large amounts of dairy products. 6 Thus, treatment of constipation includes lifestyle modifications such as a high fiber diet, more exercise, and increased fluid intake. 7 Medications for chronic constipation can be categorized as bulking agents, stool softeners, osmotic and stimulant laxatives, lubiprostone (a chloride channel activator), 5-HT4 receptor agonists and guanylate cyclase-c receptor agonists. 6 Biofeedback therapy was found to play a significant role in patients with pelvic floor dysfunction. 8 However, a systematic review on chronic constipation conducted by an American College of Gastroenterology (ACG) Task Force found little evidence supporting the use of many of these agents, except for the osmotic laxatives lactulose and polyethylene glycol (PEG), which were found to be effective by improving stool frequency and stool consistency. 9 Because its pathogenesis remains unclear, therapies for FC remain limited. Thus, complementary or alternative therapies, such as acupuncture, are attractive to patients. Acupuncture has been widely used for more than 3000 years. Although evidence from clinical trials has indicated the effectiveness of acupuncture in the treatment of FC, [10] [11] [12] acupuncture is not widely accepted for the treatment of FC because of the small sample sizes of these trials and the lack of multicenter clinical trials. Thus, a systematic review may better reveal the efficacy and safety of acupuncture for the treatment of FC. The keywords used to search the Chinese databases had the same meaning as the English words. Manual searches were also performed to enlarge the search range and attempt to find unpublished studies. If unpublished trials were encountered (e.g. only the RCT protocol was published), the authors were contacted. One trial for which only the RCT protocol had been published had a sample size and experimental design that were both eligible and convincing, 13 but that trial was still collecting participants.
MATERIALS AND METHODS

Search strategy
Selection criteria
RCTs were included, regardless of language, if they compared acupuncture with no treatment, placebo acupuncture, sham acupuncture, and medication therapies in the treatment of FC. Patients were defined as having FC if they had chronic constipation for at least two months and were diagnosed using conventional medical criteria, such as ROME Ⅲ, 14 ROME Ⅱ, 14 or the Diagnostic Guidelines for Chronic Constipation in China. 15 Only trials that evaluated invasive traditional acupuncture or electro-acupuncture alone as intervention were included. Studies that evaluated combinations of acupuncture with other interventions, include massage and medications, were excluded; as were trials of other types of acupoint stimulation, such as moxibustion, massage, acupressure, cupping, auricular point sticking, acupoint application, transcutaneous electrical nerve stimulation (TENS), surface electrodes, and catgut embedded at acupoints. Primary study outcomes included effectiveness/invalidity, based on Guidelines for Clinical Research of New Traditional Chinese Medicine, 16 and the Diagnosis and Effectiveness Standard for Traditional Chinese Medicine; 17 Cleveland Clinic score (CCS); 18 and safety (side effects). Secondary outcomes included colon transit time (CTT).
Data extraction and risk of bias assessment
Two reviewers identified eligible articles from the searches of the databases and extracted data using pre-defined extraction forms. Disagreements were resolved by consensus. Data extracted included trial methods (e.g. randomized design, sample size), information about participants (e.g. inclusion criteria, age, sex ratio), interventions (e.g. acupoints, needle sizes, depths, electro-frequency, interventions in the control group), and study outcomes. The main characteristics of included studies are presented in Table 1 . Methodological quality was assessed according to Cochrane Handbook 5.1.0. 
RESULTS
Description of included studies
A total of 1141 potentially relevant articles were identified. After screening titles and abstracts, 1092 articles were excluded, because they were nonclinical trials, case reports, lacked a comparison group, or were unrelated to acupuncture for the treatment of FC. The full texts of the remaining 49 articles were evaluated; of these, 30 were excluded because intervention sessions were unclear, methodological quality was poor, diagnosis was inappropriate, outcome data were lacking, RCTs were not performed properly or they were duplicate publications. Finally, 19 studies were included ( Figure 1 ). As presented in Table 1 , all included studies assessed difference between acupuncture and medications, including both Western medications (lactulose, PEG4000, mosapride, and bisacodyl) and traditional Chinese medications (Maren pills, Tongbianling capsules, Folium sennae, Maziren pills, and Shuchang Runtong capsules), as well as no treatment, placebo acupuncture and sham acupuncture (Table 1) . Of the 13 trials with a parallel group design, [25] [26] [27] [28] [29] [30] [32] [33] [34] [35] [36] [37] [38] six compared the effects of conventional acupuncture and medications [32] [33] [34] [36] [37] [38] and seven compared electro-acupuncture and medications. [25] [26] [27] [28] [29] [30] 35 Six trials had three-armed designs, including five compared the effects of deep puncture, shallow puncture and medication [20] [21] [22] [23] 31 and one comparing acupuncture, medication and their combination. 24 16 [20] [21] [22] [23] [24] [26] [27] [28] [31] [32] [33] [34] [35] [36] [37] [38] were published in Chinese and the other three 25, [29] [30] in English.
Interventions and controls
Electroacupuncture, using a Hans-100 or G-6805 (Shanghai Huayi) apparatus, was tested in 13 trials. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] 35 The remaining trials tested traditional acupuncture. The medication intervention in five of the six three-armed trials was lactulose, [20] [21] [22] [23] 31 whereas it was plantain and senna granules, both Chinese patent medicines, in the sixth trial. 24 Seven of the 13 parallel trials used Chinese patent medicine or traditional Chinese herbs as a control. 28, 30, [32] [33] [34] [35] [36] Of the remaining six trials, one used lactulose, 25 three used PEG4000, 22, 23, 25 one used bisacodyl, 37 and one used a combination of cisapride and Maren Runchang pills.
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Quality of the included studies
The methodological quality of the included trials was not good, because of unclear random sequence generation, lack of blinding, or inadequate concealment of allocation concealment (Figure 2, 3 ). The risk of bias, both performance bias and measurement bias, was high for blinding, as it was difficult to blind patients/ caregivers regarding the use of acupuncture. In only found among these trials (P = 0.05, I 2 = 46%). Using a random effects model, the pooled results of effectiveness/invalidity showed that acupuncture was significantly more effective than Western medications (OR = 4.88; 95% CI, 2.14 to 11.15, P = 0.0002) and tended to be more effective than Chinese medications (OR = 2.27; 95% CI, 0.99 to 5.20, P = 0.05). Generally, the effect of acupuncture was significantly higher than that of medications (OR = 2.88; 95% CI, 1.54 to 5.39, P = 0.0009) ( Figure 4A ). Pooled results showed that short-term (< 15 days) acupuncture treatment had significantly greater effects than medications (OR = 3.78; 95% CI, 1.96 to 7.31, P < 0.0001), but long-term (≥ 15 days) acupuncture did not have a significantly greater effect than medications (OR = 1.18; 95% CI, 0.66 to 2.09, P = 0.58) ( Figure 4B ). There were no significant publication biases as showed by a regression test for funnel plot asymmetry (P = 0.13) ( Figure 5A ). Nine trials reported short-term CCS data. There was significant heterogeneity among these trials (P < 0.000 01, I 2 = 90% ). A random effects model showed that CCS tended to be lower in patients undergoing acupuncture than in those treated with Western (SMD = -0.36; 95% CI, -0.84 to 0.13, P = 0.15) and Chinese (SMD = -1.17; 95% CI, -2.54 to 0.21, P = 0.10) medications. Total CCS was significantly lower in patients undergoing acupuncture than in patients treated with all types of medications (SMD = -0.53, 95% CI; -0.98 to -0.08, P = 0.02) ( Figure 4C ). Pooled results showed that longer-term (≥ 15 days) acupuncture treatment had significantly greater effects than medications (SMD = -0.54; 95% CI, -1.03 to -0.05, P = 0.03), whereas short-term treatment ( < 15 days) did not differ significantly (SMD = -0.44; 95%CI, -0.95 to 0.07, P = 0.09) ( Figure 4D ). There were no significant publication biases, as showed by regression tests for funnel plot asymmetry (P = 0.98) ( Figure 5B ). Five trials assessed the short-term effects of acupuncture on CTT; these trials showed significant heterogeneity (P = 0.02, I 2 = 59%). Reductions in CTT in patients undergoing acupuncture therapy were similar to those in patients receiving medications (SMD = -0.19; 95% CI, -0.45 to 0.08, P = 0.16), including both Chinese (SMD = 0.00; 95% CI, -0.25 to 0.25, P = 1.00) and Western (SMD = -0.24; 95% CI, -0.57 to 0.09, P = 0.15) medications ( Figure 4E ). Pooled results showed that acupuncture for < 15 days had a significantly greater effect than medication (SMD = -1.12; 95% CI, -1.67 to -0.58, P < 0.0001), whereas their longer-term effects at ≥15 days, Gao JY et al 2010 27 Geng T et al 2011 21 Gu H et al 2010 31 Guo LK et al 2011 24 Ji XQ et al 2005 31 Luo ZK 2003 37 Peng JM et al 2009 26 Peng WN et al 2010 23 Ren YY 2011 34 Wang CW et al 2010 20 Wang LS et al 2006 33 Xia CF et al 2006 36 Yang DL et al 2010 22 Yang ZL et al 2008 35 Zhang CX et al 2010 were similar (SMD = -0.04; 95% CI, -0.20 to 0.13, P = 0.66) ( Figure 4F ).
Long-term effects of acupuncture versus medication
Four studies reported the effectiveness/invalidity data of long term (≥ 15 days) treatment. There was significant heterogeneity among these trials (P < 0.000 01, I 2 = 88% ). Using a random effects model, acupuncture showed significantly greater effectiveness/invalidity than either Western (OR = 26.00; 95% CI, 2.92 to 231.31, P = 0.003) or Chinese (OR = 11.79; 95% CI, 1.45 to 95.76, P = 0.02) medications, or the two to- -3.00-2.00-1.00 0.00 1.00 2.00 3.00
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A B Figure 5 Funnel plots assessing short-term effectiveness/invalidity and short-term Cleveland Clinic score A: short-term effectiveness/invalidity; B: short-term Cleveland Clinic score.
gether (OR = 13.83; 95% CI, 2.32 to 82.42, P = 0.004) ( Figure 6A ). Pooled results showed that acupuncture had greater effectiveness/invalidity than medication for < 15 days (OR = 26.00; 95% CI, 2.92 to 231.31, P = 0.003), but not for ≥ 15 days (OR = 7.23; 95% CI, 0.68 to 77.00, P = 0.10) ( Figure 6B ). Three trials reported long-term CCS data, with significant heterogeneity among these trials (P = 0.002, I 2 = 80% ). Using a random effects model, acupuncture showed significantly better effects than Chinese medication (SMD = -0.73; 95% CI, -0.99 to -0.47, P < 0.000 01), but was similar to Western medications (SMD = -0.50; 95% CI, -1.41 to 0.41, P = 0.28). As a result, total CCS was significantly lower in patients undergoing acupuncture than medications (SMD = -0.57; 95% CI, -1.12 to -0.03, P = 0.04) ( Figure 6C ). Pooled results showed that acupuncture for < 15 days yielded better results than medications (SMD = -1.40; 95% CI, -1.97 to -0.83, P < 0.000 01), whereas acupuncture and medications for ≥ 15 days did not differ significantly (SMD = -0.33; 95% CI, -0.87 to 0.20, P = 0.22) ( Figure 6D ). Two trials reported long-term CTT, with CTT being significantly lower in acupuncture than in medication groups (SMD = -18.60; 95% CI, -27.91 to -9.30, P < 0.0001) ( Figure 6E ). As participants in both trials were treated for more than 15 days, pooled results again showed that acupuncture ≥ 15 days yielded the same results ( Figure 6F ).
Adverse effects
Four of nineteen trials reported specific side effects (nausea and vomiting, bloating, bellyache, light diarrhea or positive fecal occult blood). There was no significant heterogeneity among these trials (P = 0.90, I 2 = 0%). Using a fixed effects model, the incidence of adverse effects was found to be significantly lower in patients undergoing acupuncture than those receiving 
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Western medications (RR = 0.21; 95% CI, 0.06 to 0.72, P = 0.01) and tended to be lower in patients undergoing acupuncture than those receiving Chinese medications (RR = 0.19; 95% CI, 0.04 to 1.08, P = 0.06). The total incidence of adverse effects was significantly lower in the acupuncture than in the medication groups (RR = 0.21; 95% CI, 0.08 to 0.56, P = 0.002) ( Figure 7A ). Pooled results showed that the incidence of adverse effects was significantly lower in patients undergoing acupuncture than receiving medications for ≥ 15 days (RR = 0.21; 95% CI, 0.08 to 0.56, P = 0.007), but did not differ significantly between patients receiving acupuncture and medications for < 15 days (RR = 0.19; 95% CI, 0.02 to 1.53, P = 0.12) ( Figure 7B ).
DISCUSSION
FC can have deleterious effects on patient QOL. Acupuncture has been reported to have positive effects on self-regulation disorders and functional diseases. Although many clinical trials have tested acupuncture therapy for FC, few systematic reviews in English have comprehensively evaluated the effects of acupuncture on FC. This review indicated that, in patients with FC, acupuncture had greater short-term and long-term efficacies than medications, especially Western medications. Moreover, a short treatment course of acupuncture for two weeks was sufficient to yield these benefits. The effectiveness/invalidity and CCS data together comprehensively evaluated the clinical symptoms in patients with FC, including stool frequency, stool consistency and associated symptoms. Pooled effectiveness/invalidity data were dichotomized prior to analysis; this analysis reflected the numbers of patients effectively treated, but did not indicate specific effectiveness. CCS is a quantitative measure of effectiveness, which can better reflect treatment results. Moreover, CCS is considered more objective than effectiveness/invalidity, with the former incorporating definitive criteria about the degree of FC based on seven types of clinical symptoms. 16 CTT is another objective parameter, measuring colonic transit time, and can indicate the degree of constipation. Our Meta-analysis included five studies that estimated the effectiveness using CTT. Although our research method was strict, the quality of the included studies was relatively poor, resulting in marked heterogeneity. Pooled results demonstrated either a trend or a significant difference in favor of acupuncture therapy, although the results might have been affected by heterogeneities for short-term CCS outcomes and all long-term outcomes. Heterogeneities may have been caused by different rating scales for effectiveness/invalidity and by the characteristics of the participants enrolled in different studies. Heterogeneity may also have been affected by the different interventions in control groups, differences in stimulated acupuncture points or even differences in doctor-patient relationships. The poor quality of the included trials suggests the need for well-designed, multicenter RCTs to assess the effectiveness of acupuncture for FC. Acupuncture is regarded as generally safe, with a low incidence of side effects. In contrast, patients receiving the various medications reported various gastrointestinal side effects, including nausea and vomiting, bloating, bellyache, light diarrhea and positive fecal occult blood tests. None of the patients in any of the included trials experienced severe adverse events. These findings suggest that acupuncture may be safer than medications, especially Western medications. This systematic review has several limitations. Firstly, all but one of the included trials were of patients in mainland China. This resulted in a high risk of selection bias. Whether the results reported here are valid and applicable to other ethnic groups remains unclear. Secondly, most of the studies were of poor quality, without a blinding method or concealment of allocation. This may have resulted in potential biases in patient selection, treatment administration and assessment of results. This may have led to an overestimation of the effectiveness of acupuncture in treating FC. Compared with medication, especially with Western medication, acupuncture yielded better outcomes in patients with FC. Acupuncture was safer and more effective, with treatment for about two weeks being sufficient. However, the low methodological quality, small sample size, unidentified risk of bias and various evaluation indexes of the trials included in this Meta-analysis indicates the need for large, multicenter RCTs assessing the effectiveness and safety of acupuncture in patients with FC.
